TickerFacts.

BioNexus Gene Lab Corp (BGLC): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2025-08-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

2.42M
As of 2025-12-31
2.42M
As of 2026-06-30
171.22M2018-12-31: 74.63M2019-12-31: 102.73M2020-12-31: 171.22M2021-12-31: 171.22M2022-12-31: 14.48M2023-12-31: 17.67M2024-12-31: 1.80M2025-12-31: 2.42M2.42M
2018-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-312.42M+34.5%2026-04-14, Balance as of period end
2024-12-311.80Mn/c2026-04-14, Balance as of period end
2023-12-3117.67M+22.0%2025-04-15, Balance as of period end
2022-12-3114.48M-91.5%2024-04-16, Balance as of period end
2021-12-31171.22M0.0%2023-03-31, Balance as of period end
2020-12-31171.22M+66.7%2022-04-06, Balance as of period end
2019-12-31102.73M+37.7%2021-03-30, Balance as of period end
2018-12-3174.63Mn/a2020-03-31, Balance as of period end